Page 99 - 南京医科大学学报自然科学版

第41卷第5期 钱唯韵，马冰沁，严 淑，等. 血清NGAL与NLR在代谢综合征中的预测价值［J］.
2021年5月 南京医科大学学报（自然科学版），2021，41（05）：725-729 ·729 ·

［11］ MOSIALOU I，SHIKHEL S，LUO N，et al. Lipocalin ⁃ 2 kidney disease［J］. Kidney Blood Press Res，2018，43
counteracts metabolic dysregulation in obesity and diabe⁃ （4）：1255-1262
tes［J］. J Exp Med，2020，217（10）：e20191261 ［17］ YUAN G，QIAN W，PAN R，et al. Reduced circulating
［12］ SONG E，FAN P，HUANG B，et al. Deamidated lipocalin⁃ oxytocin and high⁃molecular⁃weight adiponectin are risk
2 induces endothelial dysfunction and hypertension in di⁃ factors for metabolic syndrome［J］. Endocr J，2016，63
etary obese mice［J］. J Am Heart Assoc，2014，3（2）： （7）：655-662

e000837 ［18］ LIU C C，KO H J，LIU W S，et al. Neutrophil⁃to⁃lympho⁃
［13］ ABELLA V，SCOTECE M，CONDE J，et al. The potential cyte ratio as a predictive marker of metabolic syndrome
of lipocalin ⁃ 2/NGAL as biomarker for inflammatory and ［J］. Medicine（Baltimore），2019，98（43）：e17537
metabolic diseases［J］. Biomarkers，2015，20（8）：565- ［19］ VICHAYA E G，GROSS P S，ESTRADA D J，et al. Lipo⁃
571 calin⁃2 is dispensable in inflammation⁃induced sickness
［14］ EILENBERG W，STOJKOVIC S，PIECHOTA⁃POLANC⁃ and depression ⁃ like behavior［J］. Psychopharmacology
ZYK A，et al. Neutrophil gelatinase associated lipocalin （Berl），2019，236（10）：2975-2982
（NGAL）is elevated in type 2 diabetics with carotid artery ［20］ SINGH R G，NGUYEN N N，CERVANTES A，et al. Cir⁃
stenosis and reduced under metformin treatment［J］. Car⁃ culating levels of lipocalin⁃2 are associated with fatty pan⁃
diovasc Diabetol，2017，16（1）：98 creas but not fatty liver［J］. Peptides，2019，119：170117
［15］ ZHANG D，YE S，PAN T. The role of serum and urinary ［21］ JAHANGIRY L，FARHANGI M A，REZAEI F. Framing⁃
biomarkers in the diagnosis of early diabetic nephropathy ham risk score for estimation of 10⁃years of cardiovascu⁃
in patients with type 2 diabetes［J］. PeerJ，2019，7：e7079 lar diseases risk in patients with metabolic syndrome［J］.
［16］SEIBERT F S，SITZ M，PASSFALL J，et al. Prognostic val⁃ J Health Popul Nutr，2017，36（1）：36
ue of urinary calprotectin，NGAL and KIM⁃1 in chronic ［收稿日期］ 2021-01-07

（上接第717页） out EBV diseases［J］. Blood，2016，127（16）：2007-2017
hybridization in diffuse large B⁃cell lymphoma［J］. Clin ［14］ HOHAUS S，SANTANGELO R，GIACHELIA M，et al.
Microbiol Infect，2015，21（6）：596-602 The viral load of Epstein⁃Barr virus（EBV）DNA in periph⁃
［11］ LIANG J H，LU L，ZHU H Y，et al. The prognostic role of eral blood predicts for biological and clinical characteris⁃
circulating Epstein⁃Barr virus DNA copy number in angio⁃ tics in Hodgkin lymphoma［J］. Clin Cancer Res，2011，17
immunoblastic T⁃cell lymphoma treated with dose⁃adjust⁃ （9）：2885-2892
ed EPOCH［J］. Cancer Res Treat，2019，51（1）：150-157 ［15］ KANAKRY J A，LI H，GELLERT L L，et al. Plasma Ep⁃
［12］ LIANG J H，WANG L，PETER GALE R，et al. Efficacy of stein⁃Barr virus DNA predicts outcome in advanced Hodg⁃
pegaspargase，etoposide，methotrexate and dexametha⁃ kin lymphoma：correlative analysis from a large North
sone in newly diagnosed advanced⁃stage extra⁃nodal natu⁃ American cooperative group trial［J］. Blood，2013，121
ral killer/T⁃cell lymphoma with the analysis of the progno⁃ （18）：3547-3553
sis of whole blood EBV⁃DNA［J］. Blood Cancer J，2017，7 ［16］KIM S J，YOON D H，JACCARD A，et al. A prognostic in⁃
（9）：e608 dex for natural killer cell lymphoma after non⁃anthracy⁃
［13］ KANAKRY J A，HEGDE A M，DURAND C M，et al. The cline⁃based treatment：a multicentre，retrospective analy⁃
clinical significance of EBV DNA in the plasma and pe⁃ sis［J］. Lancet Oncol，2016，17（3）：389-400
ripheral blood mononuclear cells of patients with or with⁃ ［收稿日期］ 2020-12-23